PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 71 filers reported holding PASSAGE BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $19,206,000 | -24.8% | 1,928,315 | 0.0% | 0.67% | -25.5% |
| Q2 2021 | $25,531,000 | -24.3% | 1,928,315 | 0.0% | 0.90% | -21.2% |
| Q1 2021 | $33,707,000 | -31.6% | 1,928,315 | 0.0% | 1.14% | -27.9% |
| Q4 2020 | $49,307,000 | +95.0% | 1,928,315 | 0.0% | 1.58% | +81.4% |
| Q3 2020 | $25,280,000 | -52.0% | 1,928,315 | 0.0% | 0.87% | -62.3% |
| Q2 2020 | $52,701,000 | +77.7% | 1,928,315 | +2.4% | 2.32% | +14.6% |
| Q1 2020 | $29,662,000 | – | 1,883,315 | – | 2.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |